Pharmaceutical Price Regulation - Is the government being two-faced?

Last Updated: Monday, September 23, 2013, 08:58

Globally, a blazing battle rages on regarding governmental curbs on Big Pharma’s intellectual property rights so as to fulfill the obligation of making the human right to health a reality.

9 drug firms to be fined Rs 2500 cr for overpricing: Report

Last Updated: Friday, July 19, 2013, 19:25

Soon, many big names in the pharma industry will have to bite a bitter pill of Rs 2500 crore as penalty for drugs overpricing.

Gulf countries wooing Indian pharma cos: Report

Last Updated: Monday, April 1, 2013, 13:27

According to Alpen Capital's The GCC pharmaceutical Industry Outlook, signing of the impending free trade agreement between the GCC and India will further open up the market for Indian companies.

The Compulsions and Repercussions of Compulsory Licensing

Last Updated: Friday, October 12, 2012, 17:39

The recent erosion of investor confidence in India that is doing the rounds in corporate circles is due to a variety of self-defeating strategies that have been adopted by the government.

New drug pricing policy may impact MNCs most: Analysts

Last Updated: Sunday, September 30, 2012, 15:56

The new pricing policy finalised by the group of ministers last week will take the number of essential drugs under price control regime to as many as 348.

The Compulsions and Repercussions of Compulsory Licensing

Last Updated: Sunday, September 2, 2012, 17:23

The recent erosion of investor confidence in India that is doing the rounds in corporate circles is due to a variety of self-defeating strategies that have been adopted by the government.